SCHEMBL6204506

SCHEMBL6204506

O=C(O)c1ccc(F)c(F)c1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
ALDH1A1 P00352 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP3A4 P08684 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.40
PKM P14618 1/20 0.39
MAP2K2 P36507 1/20 0.39
MAP2K1 Q02750 1/20 0.39
DTYMK P23919 1/20 0.39
CDK2 P24941 1/20 0.38
AKR1C2 P52895 1/20 0.38
AKR1C1 Q04828 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
ALB P02768 1/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18306112 0.87 ALDH1A1 (0.42) CES2CES1ALDH1A1TDP1CYP3A4
SCHEMBL4960492 0.87 ALDH1A1 (0.42) CES2CES1ALDH1A1TDP1CYP3A4
SCHEMBL28252852 0.81 ALB (0.47) ALDH1A1TDP1CYP3A4ALOX15TSHR
SCHEMBL28352668 0.81 TSHR (0.45) CES2CES1ALDH1A1TDP1CYP3A4
SCHEMBL21750002 0.81 ALDH1A1 (0.41) ALDH1A1TDP1CYP3A4ALOX15TSHR
SCHEMBL27783720 0.81 TSHR (0.49) ALDH1A1TDP1CYP3A4ALOX15TSHR
SCHEMBL18225454 0.81 ALDH1A1 (0.49) ALDH1A1TDP1CYP3A4ALOX15TSHR
SCHEMBL30252887 0.81 TDP1 (0.54) CES2CES1ALDH1A1TDP1CYP3A4
SCHEMBL3086799 0.80 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4ALOX15TSHR
SCHEMBL543918 0.80 TSHR (0.51) ALDH1A1TDP1CYP3A4ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1507776-A1 2-OXO-1,3,4-TRIHYDROQUINAZOLINYL DERIVATIVES FOR THE TREATMENT OF CELL PROLIFERATION-RELATED DISORDERS Amgen Inc. (US) 2005-02-23 EP disclosed
WO-2003101985-A1 2-OXO-1,3,4-TRIHYDROQUINAZOLINYL DERIVATIVES FOR THE TREATMENT OF CELL PROLIFERATION-RELATED DISORDERS AMGEN INC. (US) 2003-12-11 WO disclosed
US-5003103-A Decarboxylation, chlorodenitration, catalysis OCCIDENTAL CHEMICAL CORPORATION (US) 1991-03-26 US disclosed